Drug recall · September 7, 2022
Neomycin Sulfate Tablets recall
Why: CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454, NDC 0093-1177-01
- Lots / codes
Lot #: 3007830, 3007746, 3007829, Exp. Date 10/2024
- Company
- Teva Pharmaceuticals USA Inc, Parsippany, NJ
- Distribution
- Nationwide within the United States
- Initiated
- August 23, 2022 · Voluntary: Firm initiated
- Classified
- August 30, 2022
- Reported
- September 7, 2022
- Ended
- September 7, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Neomycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.